No results for ‘’
Gian Lifecare Ltd
₹4.77
(0%)
Sat, 12 Sept 2026, 08:53 am
Health Services
Medical/Nursing Services
24.5KGian Lifecare EV/EBITDA Ratio
| Particulars | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 4.22 | 3.15 | 9.83 | 16.54 | 6.09 | 0 |
| Price to book ratio | 0 | 0.81 | 0.66 | 3.06 | 1.16 | 1.31 | 0.92 |
| Price to sales ratio | 0 | 0.65 | 0.62 | 2.78 | 1.54 | 1.98 | 2.99 |
| Price to cash flow ratio | 0 | 3.72 | 2.23 | 7.25 | 7.07 | 28.09 | 998.18 |
| Enterprise value | 0 | 6.35Cr | 6.51Cr | 42.64Cr | 16.4Cr | 24.19Cr | 16.65Cr |
| Enterprise value to EBITDA ratio | 0 | 3.04 | 2.09 | 7.02 | 8.87 | 3.93 | 17.47 |
| Debt to equity ratio | 28.78 | 0.36 | 0.28 | 0.32 | 0.30 | 0.25 | 0.30 |
| Return on equity % | 0 | 29.08 | 23.33 | 36.92 | 7.30 | 24.15 | -0.19 |
Gian Lifecare Ltd Enterprise Value to EBITDA Ratio
The Gian Lifecare Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Gian Lifecare Ltd's valuation, profitability, and overall financial performance. Tracking the Gian Lifecare Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Gian Lifecare Ltd (NSE: , BSE: 542918) is currently trading at ₹4.77, with a market capitalization of ₹4.93Cr. As a leading company in the Health services sector and Medical/Nursing services industry, monitoring the Gian Lifecare Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Gian Lifecare Ltd Enterprise Value to EBITDA Ratio Current Value
The current Gian Lifecare Ltd Enterprise Value to EBITDA Ratio stands at 17.47.
The latest Gian Lifecare Ltd Enterprise Value to EBITDA Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Gian Lifecare Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Gian Lifecare Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 17.47
- 2023: 3.93
- 2022: 8.87
- 2021: 7.02
- 2020: 2.09
The recent rise in Gian Lifecare Ltd Enterprise Value to EBITDA Ratio suggests strengthening valuation trends and improving market sentiment.
What Gian Lifecare Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Gian Lifecare Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Gian Lifecare Ltd.
Gian Lifecare Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Gian Lifecare Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Gian Lifecare Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Gian Lifecare Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.